XERS: xerispharma.com Expected earnings per share growth for next year

Public company logo of Xeris Biopharma (XERS)

Xeris Biopharma revenues rely on an ecosystem of ready-to-use glucagon injectable forms, where loyalty is driven by the convenience of pre-filled pens. The projected net profit growth rate for n+1 visualizes expert expectations, while the 2425.50 metric confirms the current level. Stable formulations guarantee a predictable cash flow, and the development of neurology and endocrinology drugs effectively diversifies market risks.

Xeris Biopharma Holdings, Inc. (XERS): Net earnings per share change forecast for next year from 07/04/2022 to 11/17/2026

Analytical breakdowns and data insights for company Xeris Biopharma Holdings, Inc. (XERS)

- share price and consensus valuation forecast:
Fundamental company valuation:XERS, xerispharma.com
Finished products of Xeris Biopharma Holdings

To minimize risks when building a position, it is critical to track the dynamics of analysts' financial model revisions, where the projected net profit growth rate for n+1 reflects the real-time adjustment of EPS expectations. Given the outsourced production model of Xeris Biopharma (XERS), this metric confirms the effectiveness of SLA agreements, demonstrating how stable operating expenses translate into sustainable profit growth.

Analysis of competing companies

VRTX (Vertex) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year ALNY (Alnylam)|Expected earnings per share growth for next year INSM (Insmed)|UTHR (United Therapeutics Corp) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year BioMarin BMRN|BBIO (BridgeBio Pharma Inc) - Net earnings per share change forecast for next year|BGM Group Ltd - Earnings growth forecast for next year|Expected earnings per share trend next year COGT (Cogent Biosciences)|KROS: Earnings growth forecast for next year|Arcturus Therapeutics Inc (ARCT) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Eton Pharma|KMDA: Expected earnings per share trend next year|Net earnings per share growth forecast for next year fulcrumtx.com (FULC)|Expected earnings per share growth for next year Abeona Therapeutics Inc. ABEO|Earnings growth forecast for next year MREO (Mereo BioPharma Group)|PLX (Protalix BioTherapeutics Inc.) - Net earnings per share change forecast for next year|PLRX - Net earnings per share growth forecast for next year|APLT - Earnings growth forecast for next year|RNTX: Earnings growth forecast for next year|Expected net earnings per share growth next year Gelteq Limited Inc (GELS)|Expected earnings per share growth for next year AYTU|Expected net earnings per share growth next year chemomab.com CMMB|Expected earnings per share growth for next year SRXH (SRx Health Solutions Inc)|PLRZ - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Aeterna Zentaris AEZS|Cyclo Therapeutics, Inc. (CYTH) - Expected net earnings per share growth next year|INZY - Net earnings per share growth forecast for next year|Expected earnings per share trend next year RPHM (Reneo Pharmaceuticals Inc.)|COSCIENS Biopharma Inc. (CSCI) - Net earnings per share growth forecast for next year